VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,922 | +78.7% | 1,372 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $20,656 | -27.8% | 686 | -22.4% | 0.00% | -50.0% |
| Q1 2023 | $28,598 | +12.9% | 884 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $25,335 | +20.6% | 884 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $21,000 | -12.5% | 884 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -54.7% | 884 | -36.1% | 0.00% | -50.0% |
| Q1 2022 | $53,000 | -17.2% | 1,384 | -30.7% | 0.00% | 0.0% |
| Q4 2021 | $64,000 | +12.3% | 1,998 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $57,000 | -33.7% | 1,918 | -23.8% | 0.00% | -42.9% |
| Q2 2021 | $86,000 | +7.5% | 2,518 | +2.4% | 0.01% | 0.0% |
| Q1 2021 | $80,000 | -10.1% | 2,458 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $89,000 | +21.9% | 2,458 | +32.3% | 0.01% | 0.0% |
| Q3 2020 | $73,000 | +942.9% | 1,858 | +838.4% | 0.01% | +700.0% |
| Q2 2020 | $7,000 | +40.0% | 198 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | – | 198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |